Episurf Medical AB (EPIS B):企業の財務・戦略的SWOT分析

◆英語タイトル:Episurf Medical AB (EPIS B) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14497
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Episurf Medical AB (Episurf Medical), formerly Diamorph Medtech AB is a medical technology company that provides patient-specific treatments of painful joint injuries. The company offers diagnosis and design of implants and surgical instruments. Its products include Episealer Femoral Twin, Episealer Trochlea Solo, Episealer Trochlea Twin, Epiguide and toolkit; and MRI protocol. Episurf Medical’s Episealer Condyle Solo is a patient-specific resurfacing implant intended for the knee condyle for the treatment of localized cartilage and underlying bone defects. The company offers patient-specific joint resurfacing implants for providing pain relief and mobility restoration. Its products are used in repair of localized cartilage and underlying bone defects in knees, trochlea area in the knee, and other condyles and trochlea areas. Episurf Medical is headquartered in Stockholm, Sweden.

Episurf Medical AB Key Recent Developments

Feb 20,2019: Episurf Medical reaches milestone of 500 implants
Feb 12,2019: Episurf: New Australian patent approval for Episurf Medical
Feb 08,2019: Episurf Medical: Year-end report 1 October – 31 December 2018
Dec 28,2018: New US patent approval for Episurf Medical
Dec 07,2018: Episurf Medical names Niles Noblitt as Senior Advisor

This comprehensive SWOT profile of Episurf Medical AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Episurf Medical AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Episurf Medical AB – Key Information
Episurf Medical AB – Overview
Episurf Medical AB – Key Employees
Episurf Medical AB – Key Employee Biographies
Episurf Medical AB – Key Operational Heads
Episurf Medical AB – Major Products and Services
Episurf Medical AB – History
Episurf Medical AB – Company Statement
Episurf Medical AB – Locations And Subsidiaries
Episurf Medical AB – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Episurf Medical AB – Business Description
Episurf Medical AB – Corporate Strategy
Episurf Medical AB – SWOT Analysis
SWOT Analysis – Overview
Episurf Medical AB – Strengths
Episurf Medical AB – Weaknesses
Episurf Medical AB – Opportunities
Episurf Medical AB – Threats
Episurf Medical AB – Key Competitors

Section 3 – Company Financial Performance Charts

Episurf Medical AB – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Episurf Medical AB, Key Information
Episurf Medical AB, Key Ratios
Episurf Medical AB, Share Data
Episurf Medical AB, Major Products and Services
Episurf Medical AB, History
Episurf Medical AB, Key Employees
Episurf Medical AB, Key Employee Biographies
Episurf Medical AB, Key Operational Heads
Episurf Medical AB, Other Locations
Episurf Medical AB, Subsidiaries
Episurf Medical AB, Key Manufacturing facilities
Episurf Medical AB, Key Competitors
Episurf Medical AB, SWOT Analysis
Episurf Medical AB, Ratios based on current share price
Episurf Medical AB, Annual Ratios
Episurf Medical AB, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Episurf Medical AB, Performance Chart
Episurf Medical AB, Ratio Charts

★海外企業調査レポート[Episurf Medical AB (EPIS B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lysogene SAS (LYS):製薬・医療:M&Aディール及び事業提携情報
    Summary Lysogene SAS (Lysogene) is a clinical research center that offers basic research and clinical development programs. The center offers clinical development of gene therapy for neurodegenerative disorders such as Parkinson and Alzheimer diseases. It also develops models in gene therapy trials …
  • Agnico-Eagle Mines Ltd:企業のM&A・事業提携・投資動向
    Agnico-Eagle Mines Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Agnico-Eagle Mines Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Ratnamani Metals and Tubes Ltd:企業の戦略・SWOT・財務情報
    Ratnamani Metals and Tubes Ltd - Strategy, SWOT and Corporate Finance Report Summary Ratnamani Metals and Tubes Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sino Land Co Ltd:企業の戦略・SWOT・財務分析
    Sino Land Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sino Land Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Astrotech Corporation:企業の戦略・SWOT・財務分析
    Astrotech Corporation - Strategy, SWOT and Corporate Finance Report Summary Astrotech Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • NW Natural Gas Co:企業の戦略的SWOT分析
    NW Natural Gas Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Meiji Holdings Co, Ltd.:企業の戦略・SWOT・財務分析
    Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Hemanext:製薬・医療:M&Aディール及び事業提携情報
    Summary Hemanext, formerly New Health Sciences Inc, is a medical technology company that develops blood storage systems. The company offers an anaerobic storage system that minimizes oxidative damage to red blood cells in storage and delivers physiologic, therapeutic, and fresher red blood cell than …
  • Peco Energy Company-エネルギー分野:企業M&A・提携分析
    Summary PECO Energy Company (PECO), a subsidiary of Exelon Corporation, is a public utility that purchases and sells electricity and gas, and provides electricity transmission and distribution, and gas distribution services. It supplies electricity and gas to residential, commercial, and industrial …
  • PG&E Corporation (PCG):企業の財務・戦略的SWOT分析
    PG&E Corporation (PCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Misen Energy AB (MISE):企業の財務・戦略的SWOT分析
    Summary Misen Energy AB (Misen), formerly Svenska Capital Oil AB is an oil and gas company that provides pipeline services. The company offers production of gas and oil fields by implementation of large-scale investment programs and introduction of modern western knowhow and technology. It offers de …
  • Euro-Diagnostica AB-医療機器分野:企業M&A・提携分析
    Summary Euro-Diagnostica AB (Euro Diagnostica) is a medical device company that manufactures and markets purified reagents and antibodies. The company offers blood based solutions, developed to aid clinicians in diagnosis, prognosis, monitoring and treatment of autoimmune diseases. It offers product …
  • Fuji Pharma Co Ltd (4554):企業の財務・戦略的SWOT分析
    Summary Fuji Pharma Co Ltd (Fuji Pharma) develops, manufactures, and commercializes pharmaceutical products. The company specializes in offering injection agents, drugs for external use, internal drugs, and diagnostic products among others. It also provides medical care products for women, acute med …
  • Groupe Le Duff S.A.(Foodservice):戦略・SWOT・企業財務分析
    Groupe Le Duff S.A.(Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Groupe Le Duff S.A.(Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Venture Life Group Plc (VLG)-製薬・医療分野:企業M&A・提携分析
    Summary Venture Life Group Plc (Venture Life) is a consumer goods company that offers ageing population products. The company's product range and pipeline comprise food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medica …
  • EVRY ASA (EVRY):企業の財務・戦略的SWOT分析
    EVRY ASA (EVRY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Owen Mumford Ltd:企業の戦略的SWOT分析
    Owen Mumford Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Innovent Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Innovent Biologics Inc (Innovent Biologics) is a biopharmaceutical company that discovers, develops and manufactures monoclonal antibodies. The company offers monoclonal antibodies such as IBI301, IBI302 and IBI303, among others. Its products are used for the treatment of non-Hodgkin’s lymph …
  • Alexza Pharmaceuticals Inc:企業の戦略的SWOT分析
    Alexza Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • AT&T Inc:戦略・SWOT・企業財務分析
    AT&T Inc - Strategy, SWOT and Corporate Finance Report Summary AT&T Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆